Esophageal candidiasis overview

Jump to navigation Jump to search


Esophageal candidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophageal candidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal candidiasis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal candidiasis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal candidiasis overview

CDC on Esophageal candidiasis overview

Esophageal candidiasis overview in the news

Blogs on Esophageal candidiasis overview

Directions to Hospitals Treating Esophageal candidiasis

Risk calculators and risk factors for Esophageal candidiasis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Esophageal candidiasis is an opportunistic infection of the esophagus by Candida albicans. The disease occurs in patients in immunocompromised states, including post-chemotherapy and in AIDS. It is also known as candidal esophagitis or monilial esophagitis.

Historical Perspective

In 1839, B. Lagenbeck from Germany described a yeast-like fungus for the first time in the human oral infection thrush and its ability to cause it.

Classification

Esophageal candidiasis is classified according to the severity of lesions seen during endoscopy into 6 grades.

Pathophysiology

Candida is a normal commensal of the skin and mucous membranes. The balance between the virulence of the fungus and the host immune defense is responsible avoiding opportunistic infection of candida. Deficiency of cell-mediated immunity or poor general status are the main risk factors for having opportunistic candidiasis. Candidiasis is usually localized to skin and mucous membranes. In rare cases, candidiasis can spread causing candidemia and distant infection. These cases are usually associated with deficient immunity . C. albicans is the main species causing infection in humans more than any other candida species.

Causes

C. albicans is the main species causing infection in humans more than any other candida species.

Differentiating esophageal candidiasis from other diseases

Esophageal candidiasis should be differentiated from other diseases causing dysphagia especially in immunocompromised patients (e.g. herpes simplex esophagitis, CMV esophagitis).

Epidemiology and Demographics

Candidiasis is the most common cause of infectious esophagitis followed by HSV esophagitis.

Risk Factors

Immunodeficiency is the most important risk factor for candida esophagitis.

Natural History, Complications and Prognosis

Candida esophagitis is very responsive to antifungal therapy. Complications can be systemic due to the spread of infection to the blood stream or local as esophageal stricture and obstruction.

Symptoms and Physical Examination

The underlying predisposing factors are usually clear on obtaining history (HIV, chemotherapy, etc ..). Odynophagia is the most common encountered symptom of esophageal candidiasis. Examination reveals signs of immunocompromisation that was the primary cause of developing esophageal thrush.

Diagnostic tests

Although the appearance of the patches during endoscopy is diagnostic for esophageal candidiasis, biopsies should be obtained to confirm the diagnosis. If the patient is not already diagnosed with HIV or another immunocompromising disease, screening should be done.

Medical therapy

Esophageal candidiasis is almost always treated with systemic antifungals (either parentral or oral). A trial of antifungal therapy is done before performing endoscopy in HIV patients with esophagitis.

Surgery

Surgical intervention is not recommended for the management of esophageal candidiasis unless complications ensue.​

Primary Prevention

There is no established method for prevention of candida esophagitis.​

Secondary prevention

There are no secondary preventive measures available for candida esophagitis.

References